ReviewGlobal health & medicine2026
Japan Pre-Entry Tuberculosis Screening (JPETS): A new phase in tuberculosis control following Japan's transition in a low-incidence era.
Review in Global health & medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In December 2024, Japan's Pre-Entry Tuberculosis Screening (JPETS) program was introduced in coordination with the Ministry of Health, Labour and Welfare (MHLW), the Ministry of Foreign Affairs, and the Immigration Services Agency to mandate tuberculosis (TB) screening for mid- to long-term visa applicants and Certificate of Eligibility applicants from selected countries with a large number of foreign-born TB cases in Japan. To date, the target countries are located in Asia, accounting for a large proportion of foreign-born TB cases in Japan. These countries also have strong labor-migration ties with Japan. Based on a quality-assured screening process at designated Panel Clinics, JPETS aims to prevent the importation of TB, reduce the risk of its domestic transmission, and ultimately contribute to global TB control. Through robust international collaboration, JPETS also incorporates safeguards to ensure fair and equitable opportunities for migrants' social participation and well-being. This article outlines the historical background of Japan's TB control, the rationale, design, and anticipated impact of JPETS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.